36
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6847 |
GSK-J1
GSK J1 |
Histone Demethylase | Chromatin/Epigenetic |
GSK-J1 是一种高效的 H3K27 组蛋白去甲基化酶抑制剂,在无细胞试验中对 JMJD3 (KDM6B) 和 UTX (KDM6A) 的 IC50 分别为 28 nM 和 53 nM,比其他测试的去甲基化酶选择性高 10 倍以上。 | |||
T11475 |
GSK-J1 lithium salt
|
Histone Demethylase | Chromatin/Epigenetic |
GSK-J1 lithium salt 是一种有效的 H3K27me3/me2-去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 的抑制剂,对 KDM6B 的 IC50值为 60 nM。 | |||
T71916 |
GSK-J1 sodium salt
|
||
GSK-J1 sodium salt is a potent inhibitor of the H3K27 histone demethylases JMJD3 and UTX. | |||
T68836 |
ADS-J1
|
||
ADS-J1 is an HIV-1 entry inhibitor that potently inhibits seminal amyloid fibrillization and block fibril-mediated enhancement of viral infection. Semen-derived amyloid fibrils, comprising SEVI (semen-derived enhancer of viral infection) fibrils and SEM1 fibrils, may remarkably enhance HIV-1 sexual transmission and are potential targets for the development of an effective microbicide. | |||
T33281 |
Melflufen
Prodrug J-1, Melflufen, Melphalan flufenamide,Melphalan flufenamide,J 1,J1,J-1 |
||
Melphalen fluoroaniline, also known as melphalen, J-1, or prodrug J-1, is a prodrug of melphalen, in which the alkylating agent melphalen is combined with fluoroaniline and has potential antitumor and antiangiogenic activities. | |||
T12908 |
SIBA
5'-Deoxy-5'-isobutylthioadenosine,5'-Isobutylthioadenosine,5ˊ-异丁硫基-5ˊ-脱氧腺苷 |
Nucleoside Antimetabolite/Analog; HSV | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
SIBA (5'-Deoxy-5'-isobutylthioadenosine) 是 SAH 的合成类似物,可作为 S-腺苷甲硫氨酸介导的甲基转移的抑制剂。它干扰多种酶活性,可逆地阻断单纯疱疹病毒 1 型病毒的繁殖。 | |||
T5512 |
JNJ16259685
.TN.T 16259685 |
GluR | Neuroscience |
JNJ16259685 (TN.T 16259685) 是选择性mGlu1 受体拮抗剂,可浓度依赖性地抑制 mGlu1 的突触的活化,IC50值为 19 nM。 | |||
T9980 |
AVJ16
|
IGF-1R | Tyrosine Kinase/Adaptors |
AVJ16作为胰岛素生长因子2 mRNA 结合蛋白家族的成员,可与某些基因的mRNA 结合来调节蛋白质翻译。 | |||
T4251 |
GJ103 sodium salt
|
ATM/ATR | DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
GJ103 sodium salt 是 GJ072 的活性类似物,它是一种通读化合物 (RTC)。它已被证明可以降低水溶液的表面张力,使分子更容易在溶液中移动。它还被证明可以降低水溶液的粘度,使分子更容易在溶液中移动。此外,它还被证明可以降低水溶液的pH 值,这会对生物体的生化和生理过程产生各种影响。 | |||
T8320 |
J14
J-14 |
Reactive Oxygen Species | Immunology/Inflammation; Metabolism; NF-κB |
J14 是一种可逆的 sulfiredoxin 抑制剂,IC50=8.1 μM。它能够抑制sulfiredoxin 诱导氧化应激,使细胞内ROS 积累,导致细胞毒性和癌细胞死亡。 | |||
T3448 |
GJ103
|
Others | Others |
GJ103 是通读化合物 GJ072 的活性类似物。一些 GJ072 类似物(例如,GJ103、GJ106、GJ109 和 GJ111)通过 FCATMpSer1981 和 IRIF 测定一致地证明了它们在所有三种 PTC 中的活性。 GJ103 具有与 RTC13 或 RTC14 相似的通读活性,但比 RTC13 和 RTC14 对 A-T 细胞的耐受性更高。 | |||
TP1906L1 |
DPC AJ1951 acetate
|
Thyroid hormone receptor(THR) | Endocrinology/Hormones |
DPC-AJ1951 acetate 是一种 14 个氨基酸的肽,可作为甲状旁腺激素 (PTH)/PTH 相关肽受体 (PPR) 的有效激动剂。在骨吸收的体外和体内测定中表征了它的活性。 | |||
T9104 |
TJ191
|
Apoptosis | Apoptosis |
TJ191 是一种选择性抗癌试剂,靶向低 TβRIII 表达的恶性T 细胞白血病/淋巴瘤细胞,可研究癌症。 | |||
T75942 |
DPC-AJ1951 TFA
|
||
DPC-AJ1951 TFA,是一种含有14个氨基酸的肽类化合物,有效充当甲状旁腺激素(PTH)/PTH相关肽受体(PPR)激动剂,在体外及体内骨吸收实验中展现活性。 | |||
T79387 |
YJ182
|
||
YJ182为NDM-1抑制剂(IC50:0.23 μM)。该化合物同样针对IMP-1、VIM-2、GIM-1和MMP-2具有抑制作用,其IC50值分别为0.25 μM、0.61 μM、0.49 μM及6.92 μM。YJ182适用于细菌感染的研究领域。 | |||
T37409 |
DPC-AJ1951 (trifluoroacetate salt)
DPC-AJ1951 (trifluoroacetate salt) |
||
DPC-AJ1951 is a peptide agonist of the parathyroid hormone (PTH)/PTH-related peptide receptor (PPR; EC50 = 0.15 nM in HEK293 cells expressing human PPR). It induces cAMP production in SAOS-2 and UMR106 cells that endogenously express human and rat PPR, respectively (EC50s = 2.2 and 1.1 nM, respectively). DPC-AJ1915 stimulates osteoclast-mediated bone resorption in fetal rat long-bone explant cultures and increases collagen synthesis and cell proliferation in neonatal mouse parietal bone explants... | |||
T27648 |
J1075
J 1075,J-1075 |
||
J1075 is an histone deacetylase 8 (HDAC8) inhibitor. | |||
T74429 |
SJ10542
|
PROTACs | PROTAC |
SJ10542 是一种有效的选择性 JAK2/3导向苯基戊二酰亚胺 (PG)-PROTAC,对 JAK2、JAK3 和 JAK2-fusion ALL 的 DC50分别为 14、11 和 24 nM。SJ10542 利用 PG 配体作为cereblon(CRBN) 招募剂。 | |||
T78682 | SJ1461 | Epigenetic Reader Domain | Chromatin/Epigenetic |
SJ1461为一种BET抑制剂,具有口服活性。该化合物针对BRD2(BD1)、BRD2(BD2)、BRD4(BD1)与BRD4(BD2)展现出抑制作用,对应IC50值依次为1.6 nM、0.1 nM、6.5 nM及0.2 nM。 | |||
T27644 |
J1037
J 1037,J-1037 |
||
J1037 is a novel Histone Deacetylase 8 (HDAC8) inhibitor . | |||
T27665 |
JNJ1930942
JNJ-1930942,JNJ 1930942 |
||
JNJ1930942 is a novel positive allosteric modulator of the α7 nicotinic acetylcholine receptor. | |||
T32450 |
L 643717-01J10
L643717-01J10,L-643717-01J10,L643,717-01J10,L 643,717-01J10,L-643,717-01J10 |
||
L 643717-01J10 is a bioactive chemical. | |||
TP1906 |
DPC-AJ1951
DPC AJ1951 |
||
Potent 14 amino acid peptide agonist of the parathyroid hormone (PTH) receptor (EC50 = 26 nM). | |||
T77943 |
SJ1008030 TFA
|
JAK; PROTACs | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; PROTAC; Stem Cells |
SJ1008030 TFA(化合物8)是一种针对JAK2的PROTAC,能够选择性地降解JAK2蛋白。该化合物在抑制MHH-CALL-4细胞系增殖方面表现出显著效能,其IC50值为5.4 nM。SJ1008030 TFA主要应用于白血病相关研究。 | |||
T68317 |
VJ115
|
||
VJ115 is a novel chemical entity that inhibits the enzyme ENOX1, a NADH oxidase. Genetic and small molecule inhibition of ENOX1 inhibits endothelial cell tubule formation and tumor-mediated neo-angiogenesis. Inhibition of ENOX1 radiosensitizes tumor vasculature, a consequence of enhanced apoptosis. VJ115 inhibition of ENOX1 can impact expression of proteins involved in cytoskeletal reorganization and support a hypothesis in which ENOX1 activity links elevated cellular NADH concentrations with cy... | |||
T74580 |
SJ1008030
|
||
SJ1008030 (compound 8) 是一种JAK2PROTAC 选择性地降解JAK2。SJ1008030 对 MHH–CALL-4 细胞系的EC50值为 5.4 nM,IC50值为 32.09 nM。SJ1008030 可用于白血病的研究。 | |||
T27645 |
J1038
J-1038,J 1038 |
||
J1038 is a novel Histone Deacetylase 8 (HDAC8) Inhibitor . | |||
T77944 |
SJ1008030 formic
|
PROTACs | PROTAC |
SJ1008030 formic(化合物8)是一款针对JAK2的PROTAC,能够选择性地降解JAK2。该化合物在抑制MHH-CALL-4细胞系增殖方面表现出5.4 nM的IC50值,适用于白血病的研究。 | |||
T80754 |
YJ196
|
||
YJ196(Compound 59)作为一种新德里金属-β-内酰胺酶-1(NDM-1)抑制剂,拥有潜在的应用价值。 | |||
T71192 | JJ1 | ||
JJ1 is a potent, direct, and selective inhibitor of thrombin, which inhibits human platelet aggregation induced by thrombin in a concentration-dependent manner. | |||
T80433 |
δ-Buthitoxin-Hj1a
|
Sodium Channel | Membrane transporter/Ion channel |
δ-Buthitoxin-Hj1a为蝎毒肽,作为NaV1.1激动剂具有高效性,其半最大有效浓度(EC50)为17 nM。该化合物适用于Dravet综合征(DS)的研究领域。 | |||
T69437 |
NDJ18
|
||
NDJ18 is a potent and selective SIRT2 inhibitor which validated the in silico protocol and opened up the possibility for generalization and broadening of its application. The anticancer effects of the most potent compound NDJ18 were examined on the triple-negative breast cancer cell line. Results indicated that NDJ18 represents a promising structure suitable for further evaluation. | |||
T24005 |
DJ101
DJ-101,DJ 101 |
||
DJ101is an effective and metabolically stable inhibitor of tubulin. It can circumvent the drug efflux pumps responsible for multidrug resistance of existing tubulin inhibitors. | |||
T4383 |
GSK-J4 Hydrochloride
GSK J4 HCl,GSK J4 HCl (1373423-53-0 free base) |
Histone Demethylase | Chromatin/Epigenetic |
GSK-J4 Hydrochloride (GSK J4 HCl) 是 H3K27me3/me2 去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 双抑制剂,IC50分别为 8.6 和 6.6 μM。它是 GSK-J1 的乙酯衍生物,体外 IC50 值大于 50 μM。它抑制 LPS 诱导的人原代巨噬细胞产生 TNF-α,IC50值为 9 μM。 | |||
T3100 |
GSK-J4
GSK J4 HCl |
Apoptosis; Histone Demethylase | Apoptosis; Chromatin/Epigenetic |
GSK-J4 (GSK J4 HCl) 是 H3K27me3/me2 去甲基化酶JMJD3/KDM6B 和UTX/KDM6A 双抑制剂,IC50分别为 8.6 μM 和 6.6 μM。它是 GSK-J1 的细胞通透性前药,可诱导内质网应激相关的细胞凋亡。它抑制 LPS 诱导的人原代巨噬细胞产生 TNF-α,IC50值为 9 μM。 | |||
T11476 |
GSK-J2
|
Others | Others |
GSK-J2, an isomer of GSK-J1, haven't any specific activity. GSK-J1 is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T25562 |
Justicidin D
Neojusticin A,Neojusticin,Lignan J1 |
||
Justicidin D is a lignan that has antiviral activities. |